Epi CanaryEpi Canary
  • Home
  • Feed
  • Synthesis
  • Assessments
  • Scopes
  • Reliability
  • Sources
Epi Canary — Epidemic IntelligenceEvidence-led epidemic intelligence. Source-attributed evidence.
Arcede logoMade by Arcede

Public note

For situational awareness and research transparency. Not medical advice.

Needs resolution

This prediction reached its horizon without auto-resolution. Our synthesis agents are reviewing. Check back, or contribute your assessment.

Novel Pathogen Detectionexpired

Field-circulating H5N1 clade 2.3.4.4b isolates will be confirmed via published receptor binding specificity assay to demonstrate measurable human (α-2,6 sialic acid) receptor affinity alongside avian (α-2,3) affinity by Q3 2026, based on ongoing receptor binding specificity analyses of current strains.

System-generated assessment. This assessment remains under review until the stated horizon or until sufficient evidence allows evaluation.

Moderate confidence

Confidence in this assessment
50%

The evidence is meaningful, but there is still material uncertainty. Based on 8 linked evidence items and assessed against Sep 30, 2026.

Assessed through Sep 30, 2026·8 linked evidence items·Tracking since Apr 14, 2026

02

How this assessment will be evaluated

The criteria the system uses to determine whether this assessment is borne out by the stated horizon.

Automated

Method

Evidence Match

The condition the system checks for when evaluating this assessment.

Minimum source quality

T1Primary Institutional

Evidence must meet or exceed this credibility tier to count toward evaluation.

Required terms

field-circulatingspecificitydemonstratemeasurable

03

Evidence quality mix

Tracking since Apr 14, 2026.

T11
T27
▸Integrity referencesCryptographic hashes for verification

Registration

06

Scope synthesis

The current analyst narrative for this scope.

Open synthesis →

H5N1 risk elevated across multiple fronts: Cambodia sustaining human spillover, semen-RNA detected in US dairy cattle, and Nepal-India poultry corridor expanding.

07

Evidence linked to this assessment

8 linked items.

Avian Influenza A(H5N1) - Mexico. To date, no further cases of human infection with influenza A(

This report is recorded in the evidence trail but is not yet linked to a tracked assessment.

T1https://www.who.int/emergencies/disease-outbreak-news/item/2025-DON564neutral
Apr 17, 2026
Analyses of receptor binding specificity of highly pathogenic avian influenza A (H5N1) viruses i

Currently interpreted as supporting evidence for 1 tracked assessment.

T2https://pubmed.ncbi.nlm.nih.gov/41725526/supports
Apr 17, 2026
Analyses of receptor binding specificity of highly pathogenic avian influenza A (H5N1) viruses i

Currently interpreted as supporting evidence for 1 tracked assessment.

T2https://pubmed.ncbi.nlm.nih.gov/41725526/supports
Apr 17, 2026
Analyses of receptor binding specificity of highly pathogenic avian influenza A (H5N1) viruses i

Currently interpreted as supporting evidence for 1 tracked assessment.

T2https://pubmed.ncbi.nlm.nih.gov/41725526/supports
Apr 15, 2026
Analyses of receptor binding specificity of highly pathogenic avian influenza A (H5N1) viruses i

Currently interpreted as supporting evidence for 1 tracked assessment.

T2https://pubmed.ncbi.nlm.nih.gov/41725526/supports
Apr 15, 2026
Analyses of receptor binding specificity of highly pathogenic avian influenza A (H5N1) viruses i

Currently interpreted as supporting evidence for 1 tracked assessment.

T2https://pubmed.ncbi.nlm.nih.gov/41725526/supports
Apr 14, 2026
Analyses of receptor binding specificity of highly pathogenic avian influenza A (H5N1) viruses i

Currently interpreted as supporting evidence for 1 tracked assessment.

T2https://pubmed.ncbi.nlm.nih.gov/41725526/supports
Apr 13, 2026
Receptor-binding specificity and antigenic properties of a genotype D1.1 A(H5N1) influenza virus

Currently interpreted as supporting evidence for 1 tracked assessment.

T2https://pubmed.ncbi.nlm.nih.gov/41824556/supports
Apr 17, 2026

Integrity anchor

Brier 0.202

19 resolved novel pathogen detection predictions.